# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Michael Ha maintains Universal Health Servs (NYSE:UHS) with a Outperform and raises the price target from $236...
Cantor Fitzgerald analyst Sarah James reiterates Universal Health Servs (NYSE:UHS) with a Neutral and maintains $219 price t...
Cantor Fitzgerald analyst Sarah James reiterates Universal Health Servs (NYSE:UHS) with a Neutral and maintains $219 price t...
UBS analyst A.J. Rice maintains Universal Health Servs (NYSE:UHS) with a Buy and raises the price target from $247 to $267.
Goldman Sachs analyst Jamie Perse maintains Universal Health Servs (NYSE:UHS) with a Buy and raises the price target from $2...
Wells Fargo analyst Stephen Baxter maintains Universal Health Servs (NYSE:UHS) with a Overweight and raises the price target...